3 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Paul S. Bernstein: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Moran AMD Genetic Testing Assessment Study Early disclosure of genetic testing results, Late disclosure of genetic testing results - Age-Related Macular Degeneration, Genetic Testing | Phase 2 | Completed | Paul S. Bernstein | 80 | 2022-08-03 | 2025-10-01 |
| Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects Carotenoid Group, Control Group - Nutrient Deficiency, Pregnancy Related | Phase 2 | Completed | Paul S. Bernstein | 47 | 2019-09-26 | 2023-07-11 |
| The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel) zeaxanthin - Idiopathic Juxtafoveal Telangiectasia | Completed | Paul S. Bernstein | 8 | 2011-11-01 | 2017-06-23 |
Idiopathic Juxtafoveal Retinal Telangiectasia (1) · Macular Degeneration (1)
Zeaxanthins (2) · Control Groups (1) · Lutein (1)
United States (3)
Paul Bernstein, MD, PhD (1) · Paul S Bernstein, MD, PhD (1) · Paul S. Bernstein, M.D., Ph.D. (1)
PMID 33888136, PMID 37247819, PMID 37337222
R21EY033579 (1)